A growing body of evidence supports the notion that misexpression of the HOXA9 homeobox gene is a common and critical event in human acute myelogenous leukemia (AML) and is critical to the induction and maintenance of the malignant phenotype [9,11]. The gene discussed is HOXA9; the disease is acute myeloid leukemia.